Showing results (2081-2090 of 2,436) with videos related to

Sort By:
Pageof 244
European Urology Open Science|November 24, 2025
Efficacy of Enfortumab Vedotin After Platinum Chemotherapy and Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Real-World Analysis of the ARON-2EV CohortOndrej Fiala, Francesco Grillone, Kazutoshi Fujita, et al.
Clinical & Experimental Metastasis|November 21, 2025
Time to metastasis as a prognostic factor in metastatic urothelial carcinoma: results from the ARON-2 studyRenate Pichler, Gerald Klinglmair, Kirstin Binz, et al.
Prostate Cancer and Prostatic Diseases|January 7, 2026
Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 studyThomas Büttner, Mimma Rizzo, Laura Bernal Vaca, et al.
Journal of Medicinal Chemistry|December 11, 2012
Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitorsGiuseppe La Regina, Ruoli Bai, Whilelmina Maria Rensen, et al.
Genome Research|June 21, 2013
The complex SNP and CNV genetic architecture of the increased risk of congenital heart defects in Down syndromeM Reza Sailani, Periklis Makrythanasis, Armand Valsesia, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2021
Telomere dysfunction instigates inflammation in inflammatory bowel diseaseDeepavali Chakravarti, Rumi Lee, Asha S Multani, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2023
Targeting DNA2 Overcomes Metabolic Reprogramming in Multiple MyelomaNatthakan Thongon, Feiyang Ma, Pamela Lockyer, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2024
Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinationsLorena Incorvaia, Fernando Sabino Marques Monteiro, Francesco Massari, et al.
Nature Reviews. Immunology|September 11, 2020
The global response to the COVID-19 pandemic: how have immunology societies contributed?Faith Osier, Jenny P Y Ting, John Fraser, et al.
Cancer Immunology, Immunotherapy : CII|March 24, 2026
Real-world effectiveness of avelumab, pembrolizumab, and enfortumab vedotin in patients with advanced urothelial carcinoma with squamous differentiation (ARON-2EV)Veronica Mollica, Francesco Massari, Kazutoshi Fujita, et al.
Pageof 244